ACCORD MEMORY IN DIABETES (MIND) SUB-STUDY

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。记忆测试将每两年进行一次，总共三次，研究期间将进行两次核磁共振扫描。将对ACCORD参与者进行研究，以确定与标准治疗方案相比，强化治疗是否会降低或增加记忆损伤和日常功能的风险。早期的研究表明，患有2型糖尿病的人比其他人更有可能经历记忆力下降。目前尚不清楚糖尿病的强化治疗对记忆力有何影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Memory tests will be performed once every two years, for a total of three times, and MRI scans will be performed two times during the study. ACCORD participants will be studied to determine if intensive therapy will reduce or increase the risks of memory impairment and daily functioning when compared to the standard treatment protocol. Earlier studies indicate that individuals with type 2 diabetes are more likely than others to experience decline in memory. It is not known how intensive treatment of diabetes affects memory.